Healthconn Corp. (TPEX:6665)
20.40
-0.10 (-0.49%)
At close: Feb 11, 2026
Healthconn Market Cap
Healthconn has a market cap or net worth of 925.14 million as of February 13, 2026. Its market cap has decreased by -2.39% in one year.
Market Cap
925.14M
Enterprise Value
827.40M
Revenue
1.20B
Ranking
n/a
PE Ratio
59.24
Stock Price
20.40
Market Cap Chart
Since November 23, 2017, Healthconn's market cap has decreased from 8.08B to 925.14M, a decrease of -88.55%. That is a compound annual growth rate of -23.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 925.14M | 1.75% |
| Dec 31, 2025 | 909.27M | 8.97% |
| Dec 31, 2024 | 834.44M | -35.44% |
| Dec 29, 2023 | 1.29B | -18.45% |
| Dec 30, 2022 | 1.58B | -26.87% |
| Dec 30, 2021 | 2.17B | -5.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| Taiwan Advance Bio-Pharmaceutical | 990.00M |
| TCI GENE | 986.90M |
| NatureWise Biotech & Medicals | 982.35M |
| Neith | 974.70M |